Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vax-D Medical Technologies is a medical device company that pioneered non-surgical spinal decompression therapy. Founded by Dr. Allan Dyer, the inventor of the heart defibrillator, the company developed the VAX-D (Vertebral Axial Decompression) system to treat chronic back pain, sciatica, and disc-related conditions. The technology utilizes a patented computerized table that applies logarithmic distraction tensions to the spine, creating negative intradiscal pressure to facilitate the natural healing of herniated and degenerated discs. VAX-D is marketed as a safe, non-invasive alternative to spinal surgery and is used by physicians and chiropractors in hundreds of clinics worldwide. The company's flagship products include the Genesis and Genesis G2 systems, which are supported by numerous clinical studies demonstrating significant pain reduction and improved patient mobility.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vax-D Medical Technologies.